Balasko Annemarie, Zibar Tomsic Karin, Kastelan Darko, Dusek Tina
Department of Endocrinology, University Hospital Center Zagreb, Zagreb, Croatia.
School of Medicine University of Zagreb, Zagreb, Croatia.
J Neuroendocrinol. 2022 Aug;34(8):e13172. doi: 10.1111/jne.13172. Epub 2022 Jun 20.
After successful treatment for Cushing's syndrome (CS), secondary adrenal insufficiency develops as a result of the prior suppression of the hypothalamic-pituitary-adrenal (HPA) axis by excess cortisol in the body. Until the recovery of the HPA axis, glucocorticoid replacement therapy is required to enable normal functioning of the body and prevent adrenal crisis. Significant variation in the median time of recovery of the HPA axis is found in various cohorts of CS patients ranging from several weeks to years. Despite the use of physiological glucocorticoid replacement, after cure for CS, patients often experience symptoms of glucocorticoid withdrawal syndrome (GWS). The optimal glucocorticoid regimen to reduce GWS needs to be established and requires an individualized approach aiming to avoid overtreatment at one side and minimize the risk of undertreatment and possible adrenal crisis and GWS on the other side.
在成功治疗库欣综合征(CS)后,由于体内过量皮质醇对下丘脑 - 垂体 - 肾上腺(HPA)轴的先前抑制,会出现继发性肾上腺功能不全。在HPA轴恢复之前,需要进行糖皮质激素替代治疗,以使身体正常运作并预防肾上腺危象。在不同队列的CS患者中,发现HPA轴恢复的中位时间存在显著差异,从数周到数年不等。尽管使用了生理性糖皮质激素替代治疗,但在CS治愈后,患者仍常出现糖皮质激素戒断综合征(GWS)的症状。需要建立减少GWS的最佳糖皮质激素治疗方案,这需要一种个体化的方法,一方面旨在避免过度治疗,另一方面将治疗不足以及可能的肾上腺危象和GWS的风险降至最低。